These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 17132967)
1. Spanish instrument protocol: new treatment efficacy instruments for Spanish-speaking patients in Alzheimer disease clinical trials. Sano M; Egelko S; Jin S; Cummings J; Clark CM; Pawluczyk S; Thomas RJ; Schittini M; Thal LJ; Alzheimer Dis Assoc Disord; 2006; 20(4):232-41. PubMed ID: 17132967 [TBL] [Abstract][Full Text] [Related]
2. The Spanish Instrument Protocol: design and implementation of a study to evaluate treatment efficacy Instruments for Spanish-speaking patients with Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Sano M; Mackell JA; Ponton M; Ferreira P; Wilson J; Pawluczyk S; Pfeiffer E; Thomas RG; Jin S; Schafer K; Schittini M; Grundman M; Ferris SH; Thal LJ Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S57-64. PubMed ID: 9236954 [TBL] [Abstract][Full Text] [Related]
4. Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale. Cullum CM; Saine K; Chan LD; Martin-Cook K; Gray KF; Weiner MF Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):103-8. PubMed ID: 11417663 [TBL] [Abstract][Full Text] [Related]
5. A neuropsychological test battery for use in Alzheimer disease clinical trials. Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273 [TBL] [Abstract][Full Text] [Related]
6. Test Your Memory-Spanish version (TYM-S): a validation study of a self-administered cognitive screening test. Muñoz-Neira C; Henríquez Chaparro F; Delgado C; Brown J; Slachevsky A Int J Geriatr Psychiatry; 2014 Jul; 29(7):730-40. PubMed ID: 24390843 [TBL] [Abstract][Full Text] [Related]
7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552 [TBL] [Abstract][Full Text] [Related]
8. A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study. Ferris SH; Mackell JA; Mohs R; Schneider LS; Galasko D; Whitehouse PJ; Schmitt FA; Sano M; Thomas RG; Ernesto C; Grundman M; Schafer K; Thal LJ Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S1-12. PubMed ID: 9236947 [TBL] [Abstract][Full Text] [Related]
9. Global measures: utility in defining and measuring treatment response in dementia. Reisberg B Int Psychogeriatr; 2007 Jun; 19(3):421-56. PubMed ID: 17480241 [TBL] [Abstract][Full Text] [Related]
10. The impact of the native language of Alzheimer's disease and normal elderly individuals on their ability to recall digits. Argüelles T; Loewenstein D; Argüelles S Aging Ment Health; 2001 Nov; 5(4):358-65. PubMed ID: 11767984 [TBL] [Abstract][Full Text] [Related]
11. A comparative analysis of neuropsychological test performance of Spanish-speaking and English-speaking patients with Alzheimer's disease. Loewenstein DA; Argüelles T; Barker WW; Duara R J Gerontol; 1993 May; 48(3):P142-9. PubMed ID: 8482824 [TBL] [Abstract][Full Text] [Related]
12. Performance of Spanish speakers on the Mattis dementia rating scale (MDRS). Lyness SA; Hernandez I; Chui HC; Teng EL Arch Clin Neuropsychol; 2006 Dec; 21(8):827-36. PubMed ID: 17079111 [TBL] [Abstract][Full Text] [Related]
13. [Validation of the Spanish version of the QoL-AD Scale in alzheimer disease patients, their carers, and health professionals]. Gómez-Gallego M; Gómez-Amor J; Gómez-García J Neurologia; 2012 Jan; 27(1):4-10. PubMed ID: 21570161 [TBL] [Abstract][Full Text] [Related]
14. Cross-cultural neuropsychological assessment: a comparison of randomly selected, demographically matched cohorts of English- and Spanish-speaking older adults. Jacobs DM; Sano M; Albert S; Schofield P; Dooneief G; Stern Y J Clin Exp Neuropsychol; 1997 Jun; 19(3):331-9. PubMed ID: 9268808 [TBL] [Abstract][Full Text] [Related]
15. The TE4D-Cog: a new test for detecting early dementia in English-speaking populations. Mahoney R; Johnston K; Katona C; Maxmin K; Livingston G Int J Geriatr Psychiatry; 2005 Dec; 20(12):1172-9. PubMed ID: 16315149 [TBL] [Abstract][Full Text] [Related]
16. Validation of the Spanish version of the Baylor Profound Mental Status Examination. Salmerón S; Huedo I; López-Utiel M; Soler-Moratalla I; Flores-Ruano T; Fernández-Sánchez M; Noguerón A; Doody RS; Abizanda P J Alzheimers Dis; 2016; 49(1):73-8. PubMed ID: 26444781 [TBL] [Abstract][Full Text] [Related]
20. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response. Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]